Efficacy of primary treatment with immunoglobulin plus ciclosporin for prevention of coronary artery abnormalities in patients with Kawasaki disease predicted to be at increased risk of non-response to intravenous immunoglobulin (KAICA): a
Mortality among Children with Kawasaki Disease in Japan | NEJM
Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial - The Lancet
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Frontiers | The Epidemiology and Pathogenesis of Kawasaki Disease
Children | Free Full-Text | Major Complication Following Kawasaki Disease in an Infant—The Development of Apical Infarction and Aneurysm Formation
Searching for the cause of Kawasaki disease — cytoplasmic inclusion bodies provide new insight | Nature Reviews Microbiology
The up‐to‐date pathophysiology of Kawasaki disease - Hara - 2021 - Clinical & Translational Immunology - Wiley Online Library
Figure 1 | Archives of Disease in Childhood
Recurrence of Fever After Initial Intravenous Immunoglobulin Treatment in Children With Kawasaki Disease - Masanori Yoshida, Shinji Oana, Hiroshi Masuda, Akira Ishiguro, Hitoshi Kato, Shuichi Ito, Tohru Kobayashi, Jun Abe, 2018
Epidemiologic features of Kawasaki disease in acute stages in Taiwan, 1997–2010: Effect of different case definitions in claims data analysis - ScienceDirect
Frontiers | Antibodies and Immunity During Kawasaki Disease
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
Children | Free Full-Text | Recurrent Kawasaki Disease: A Case Report of Three Separate Episodes at >4-Year Intervals
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association | Circulation
Rheumato | Free Full-Text | Kawasaki Disease: Management Challenges during COVID-19 Pandemic with an Upsurge in Multisystem Inflammatory Syndrome in Children
Frontiers | How Should We Classify Kawasaki Disease?
Exposures associated with the onset of Kawasaki disease in infancy from the Japan Environment and Children's Study | Scientific Reports
Kawasaki disease recurrence in the COVID-19 era: a systematic review of the literature | Italian Journal of Pediatrics | Full Text
Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease | Scientific Reports
33020-1.fp.png "FEVER AND BACTERIURIA IN REFRACTORY KAWASAKI DISEASE WITH CORONARY ANEURYSM: RECURRENCE OR URINARY TRACT INFECTION? | Journal of the American College of Cardiology")
FEVER AND BACTERIURIA IN REFRACTORY KAWASAKI DISEASE WITH CORONARY ANEURYSM: RECURRENCE OR URINARY TRACT INFECTION? | Journal of the American College of Cardiology
Recurrent Kawasaki disease presenting as acute airway obstruction
A case of recurrent Kawasaki disease
Late Treatment and Recurrence of Kawasaki Disease in a Moroccan Infant
